XBIOTECH INC. Earnings Per Share (Basic)
XBIOTECH INC. (XBIT) reported Earnings Per Share (Basic) of -$0.22 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- XBIOTECH INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.22.
- XBIOTECH INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.18.
- XBIOTECH INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.88.
- XBIOTECH INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.20.
- XBIOTECH INC. earnings per share, basic for fiscal 2025 was -$1.49.
- XBIOTECH INC. earnings per share, basic for fiscal 2024 was -$1.26.
- XBIOTECH INC. earnings per share, basic for fiscal 2023 was -$0.81.
- XBIOTECH INC. earnings per share, basic for fiscal 2022 was -$1.08.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.22 10-Q · filed 2026-08-13 | -$0.40 10-Q · filed 2026-08-13 | -$1.28 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.18 10-Q · filed 2026-05-14 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.49 10-K · filed 2026-03-13 |
| 2025-09-30 | -$0.20 10-Q · filed 2025-11-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.61 10-Q · filed 2025-11-12 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.06 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2026-08-13 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-14 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-05-14 |
| 2024-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1.26 10-K · filed 2026-03-13 |
| 2024-09-30 | -$0.16 10-Q · filed 2025-11-12 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.92 10-Q · filed 2025-11-12 | -$1.07 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.43 10-Q · filed 2025-08-13 | -$0.76 10-Q · filed 2025-08-13 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-08-13 |
| 2024-03-31 | -$0.33 10-Q · filed 2025-05-14 | -$0.48 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.01 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | -$0.15 10-K · filed 2024-03-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.81 10-K · filed 2025-03-18 |
| 2023-09-30 | -$0.24 10-Q · filed 2024-11-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.65 10-Q · filed 2024-11-13 | -$0.76 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-06-30 | -$0.29 10-Q · filed 2024-08-12 | -$0.41 10-Q · filed 2024-08-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$0.93 derived: net income ÷ weighted average shares · filed 2024-08-12 |
| 2023-03-31 | -$0.13 10-Q · filed 2024-05-10 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$0.65 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$1.03 derived: net income ÷ weighted average shares · filed 2024-05-10 |
| 2022-12-31 | -$0.10 10-K · filed 2024-03-15 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$1.08 10-K · filed 2024-03-15 |
| 2022-09-30 | -$0.42 10-K · filed 2024-03-15 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$0.98 10-Q · filed 2023-11-09 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-03-15 |
| 2022-06-30 | -$0.38 10-K · filed 2024-03-15 | -$0.56 10-Q · filed 2023-08-11 | -$0.77 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$0.88 derived: net income ÷ weighted average shares · filed 2024-03-15 |
| 2022-03-31 | -$0.18 10-K · filed 2024-03-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$0.50 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-03-15 |
| 2021-12-31 | -$0.21 10-K · filed 2023-03-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.58 10-K · filed 2023-03-15 |
| 2021-09-30 | -$0.11 10-K · filed 2023-03-15 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.37 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.17 10-K · filed 2023-03-15 | -$0.26 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$0.09 10-K · filed 2023-03-15 | |||
| 2020-12-31 | -$0.36 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $16.67 10-K · filed 2021-03-16 | $17.17 10-K · filed 2022-03-15 | ||
| 2019-09-30 | -$0.15 10-K · filed 2021-03-16 | |||
| 2019-06-30 | -$0.16 10-K · filed 2021-03-16 | |||
| 2019-03-31 | -$0.16 10-K · filed 2021-03-16 | |||
| 2018-12-31 | -$0.59 10-K · filed 2021-03-16 | |||
| 2017-12-31 | -$0.95 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |